በNew Jersey ለዲሜንሽያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለዲሜንሽያ የሚደረጉ 8 ጥናቶች በNew Jersey ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በNew Jersey ውስጥ ያሉ ከተሞች
Official study text (English)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06887192Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05048966A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ60 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06976203A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ60 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT06976216A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07602582Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT07012993Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ2 ፌብሩ 2026 · NCT07105709ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።